VISTAGEN THERAPEUTICS, INC. Gain (Loss) on Sale of Derivatives
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Gain (Loss) on Sale of Derivatives of $953.70 thousand for the 3-month period ending 2014-12-31, per its 10-Q filed 2015-02-17.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnSaleOfDerivatives · last filed 2015-02-17
- VISTAGEN THERAPEUTICS, INC. gain (loss) on sale of derivatives for the quarter ending 2014-12-31 was $953.70K, a 50.85% decline year-over-year.
- VISTAGEN THERAPEUTICS, INC. gain (loss) on sale of derivatives for the quarter ending 2013-12-31 was $1.94M.
| Period end | Gain (Loss) on Sale of Derivatives 3 month | Gain (Loss) on Sale of Derivatives 9 month |
|---|---|---|
| 2014-12-31 | $953.70K 10-Q · filed 2015-02-17 | $528.30K 10-Q · filed 2015-02-17 |
| 2013-12-31 | $1.94M 10-Q · filed 2015-02-17 | $3.82M 10-Q · filed 2015-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |